| Literature DB >> 29334315 |
Hassan Zalzali1, Wissam Rabeh1, Omar Najjar1, Rami Abi Ammar1, Mohamad Harajly1, Raya Saab1.
Abstract
The tumor suppressor p53, and the cyclin-dependent kinase inhibitor Ink4c, have been both implicated in spermatogenesis control. Both p53-/- and Ink4c-/- single knockout male mice are fertile, despite testicular hypertrophy, Leydig cell differentiation defect, and increased sperm count in Ink4c-/- males. To investigate their collaborative roles, we studied p53-/- Ink4c-/- dual knockout animals, and found that male p53-/- Ink4c-/- mice have profoundly reduced fertility. Dual knockout male mice show a marked decrease in sperm count, abnormal sperm morphology and motility, prolongation of spermatozoa proliferation and delay of meiosis entry, and accumulation of DNA damage. Genetic studies showed that the effects of p53 loss on fertility are independent of its downstream effector Cdkn1a. Absence of p53 also partially reverses the hyperplasia seen upon Ink4c loss, and normalizes the Leydig cell differentiation defect. These results implicate p53 in mitigating both the delayed entry into meiosis and the secondary apoptotic response that occur in the absence of Ink4c. We conclude that the cell cycle genes p53 and Ink4c collaborate in sperm cell development and differentiation, and may be important candidates to investigate in human male infertility conditions.Entities:
Keywords: Infertility; p18Ink4c; p53; spermatogenesis; tumor suppressors
Mesh:
Substances:
Year: 2018 PMID: 29334315 PMCID: PMC5969541 DOI: 10.1080/15384101.2017.1421874
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534